Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...
ATTD conference, experts debated whether patients who use continuous glucose monitoring should aim for normal glycemia.
The AID system used in the study was Tandem Diabetes Care's t:slim X2 insulin pump with Control-IQ+ technology, used in ...
A year to the day after declaring the FDA’s clearance of its automated insulin pump, Sequel Med Tech announced that its first connected continuous glucose monitor will be Abbott’s FreeSty | Greenlit ...
Jaeb Center for Health Research conducted a randomized controlled trial evaluating the impact of automated insulin delivery ...
The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...
The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income ...
Sequel Med Tech announced today that it integrated its twiist automated insulin delivery (AID) with the Abbott FreeStyle Libre 3 Plus sensor.
Medical Device Network on MSN2d
Glooko integrates Abbott’s FreeStyle Libre onto platformAbbott’s CGM device, the FreeStyle Libre, has been integrated with Glooko’s digital platform for diabetes management.
slim X2 insulin pump with Control-IQ+ technology, used in conjunction with a Dexcom G6 CGM sensor that can be used with NovoLog or Humalog U-100 insulin. The pump is indicated for use in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback